These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 37669106)

  • 1. Toward Precision Oncology in Glioblastoma with a Personalized Cancer Genome Reporting Tool and Genetic Changes Identified by Whole Exome Sequencing.
    Erdogan O; Özkaya ŞÇ; Erzik C; Bilguvar K; Arga KY; Bayraklı F
    OMICS; 2023 Sep; 27(9):426-433. PubMed ID: 37669106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multi-omics analysis of primary glioblastoma cell lines shows recapitulation of pivotal molecular features of parental tumors.
    Rosenberg S; Verreault M; Schmitt C; Guegan J; Guehennec J; Levasseur C; Marie Y; Bielle F; Mokhtari K; Hoang-Xuan K; Ligon K; Sanson M; Delattre JY; Idbaih A
    Neuro Oncol; 2017 Feb; 19(2):219-228. PubMed ID: 27571888
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical targeted exome-based sequencing in combination with genome-wide copy number profiling: precision medicine analysis of 203 pediatric brain tumors.
    Ramkissoon SH; Bandopadhayay P; Hwang J; Ramkissoon LA; Greenwald NF; Schumacher SE; O'Rourke R; Pinches N; Ho P; Malkin H; Sinai C; Filbin M; Plant A; Bi WL; Chang MS; Yang E; Wright KD; Manley PE; Ducar M; Alexandrescu S; Lidov H; Delalle I; Goumnerova LC; Church AJ; Janeway KA; Harris MH; MacConaill LE; Folkerth RD; Lindeman NI; Stiles CD; Kieran MW; Ligon AH; Santagata S; Dubuc AM; Chi SN; Beroukhim R; Ligon KL
    Neuro Oncol; 2017 Jul; 19(7):986-996. PubMed ID: 28104717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Longitudinal analysis of treatment-induced genomic alterations in gliomas.
    Erson-Omay EZ; Henegariu O; Omay SB; Harmancı AS; Youngblood MW; Mishra-Gorur K; Li J; Özduman K; Carrión-Grant G; Clark VE; Çağlar C; Bakırcıoğlu M; Pamir MN; Tabar V; Vortmeyer AO; Bilguvar K; Yasuno K; DeAngelis LM; Baehring JM; Moliterno J; Günel M
    Genome Med; 2017 Feb; 9(1):12. PubMed ID: 28153049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spatiotemporal genomic architecture informs precision oncology in glioblastoma.
    Lee JK; Wang J; Sa JK; Ladewig E; Lee HO; Lee IH; Kang HJ; Rosenbloom DS; Camara PG; Liu Z; van Nieuwenhuizen P; Jung SW; Choi SW; Kim J; Chen A; Kim KT; Shin S; Seo YJ; Oh JM; Shin YJ; Park CK; Kong DS; Seol HJ; Blumberg A; Lee JI; Iavarone A; Park WY; Rabadan R; Nam DH
    Nat Genet; 2017 Apr; 49(4):594-599. PubMed ID: 28263318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New insights for precision treatment of glioblastoma from analysis of single-cell lncRNA expression.
    Meng Q; Zhang Y; Li G; Li Y; Xie H; Chen X
    J Cancer Res Clin Oncol; 2021 Jul; 147(7):1881-1895. PubMed ID: 33693962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An absolute approach to using whole exome DNA and RNA workflow for cancer biomarker testing.
    Malhotra R; Javle V; Tanwar N; Gowda P; Varghese L; K A; Madhusudhan N; Jaiswal N; K S B; Chatterjee M; Prabhash K; Sreekanthreddy P; Rishi KD; Goswami HM; Veldore VH
    Front Oncol; 2023; 13():1002792. PubMed ID: 36994199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Whole Genome Sequencing-Based Discovery of Structural Variants in Glioblastoma.
    Wrzeszczynski KO; Felice V; Shah M; Rahman S; Emde AK; Jobanputra V; O Frank M; Darnell RB
    Methods Mol Biol; 2018; 1741():1-29. PubMed ID: 29392687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patient-derived glioblastoma cell lines with conserved genome profiles of the original tissue.
    Kim SC; Cho YE; Shin YK; Yu HJ; Chowdhury T; Kim S; Yi KS; Choi CH; Cha SH; Park CK; Ku JL
    Sci Data; 2023 Jul; 10(1):448. PubMed ID: 37438387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of novel genes by whole-exome sequencing can improve gastric cancer precision oncology.
    Lianos GD; Glantzounis GK; Bali CD; Katsios C; Roukos DH
    Future Oncol; 2017 Apr; 13(10):883-892. PubMed ID: 27897040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation of genetic alterations by whole-exome sequencing with clinical outcomes of glioblastoma patients from the Lebanese population.
    Saadeh FS; Morsi RZ; El-Kurdi A; Nemer G; Mahfouz R; Charafeddine M; Khoury J; Najjar MW; Khoueiry P; Assi HI
    PLoS One; 2020; 15(11):e0242793. PubMed ID: 33237934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Whole-exome sequencing revealed mutational profiles of giant cell glioblastomas.
    Shi ZF; Li KK; Kwan JSH; Yang RR; Aibaidula A; Tang Q; Bao Y; Mao Y; Chen H; Ng HK
    Brain Pathol; 2019 Nov; 29(6):782-792. PubMed ID: 30861589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Translational validation of personalized treatment strategy based on genetic characteristics of glioblastoma.
    Oh YT; Cho HJ; Kim J; Lee JH; Rho K; Seo YJ; Choi YS; Jung HJ; Song HS; Kong DS; Seol HJ; Lee JI; Yoon Y; Kim S; Nam DH; Joo KM
    PLoS One; 2014; 9(8):e103327. PubMed ID: 25084005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exome sequencing identifies frequent genomic loss of TET1 in IDH-wild-type glioblastoma.
    Stasik S; Juratli TA; Petzold A; Richter S; Zolal A; Schackert G; Dahl A; Krex D; Thiede C
    Neoplasia; 2020 Dec; 22(12):800-808. PubMed ID: 33142244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrated next-generation sequencing and avatar mouse models for personalized cancer treatment.
    Garralda E; Paz K; López-Casas PP; Jones S; Katz A; Kann LM; López-Rios F; Sarno F; Al-Shahrour F; Vasquez D; Bruckheimer E; Angiuoli SV; Calles A; Diaz LA; Velculescu VE; Valencia A; Sidransky D; Hidalgo M
    Clin Cancer Res; 2014 May; 20(9):2476-84. PubMed ID: 24634382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Whole-genome and multisector exome sequencing of primary and post-treatment glioblastoma reveals patterns of tumor evolution.
    Kim H; Zheng S; Amini SS; Virk SM; Mikkelsen T; Brat DJ; Grimsby J; Sougnez C; Muller F; Hu J; Sloan AE; Cohen ML; Van Meir EG; Scarpace L; Laird PW; Weinstein JN; Lander ES; Gabriel S; Getz G; Meyerson M; Chin L; Barnholtz-Sloan JS; Verhaak RG
    Genome Res; 2015 Mar; 25(3):316-27. PubMed ID: 25650244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Next-generation whole exome sequencing of glioblastoma with a primitive neuronal component.
    Xu G; Zheng H; Li JY
    Brain Tumor Pathol; 2019 Jul; 36(3):129-134. PubMed ID: 30715630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative sequence analysis of patient-matched primary colorectal cancer, metastatic, and recurrent metastatic tumors after adjuvant FOLFOX chemotherapy.
    Harada K; Okamoto W; Mimaki S; Kawamoto Y; Bando H; Yamashita R; Yuki S; Yoshino T; Komatsu Y; Ohtsu A; Sakamoto N; Tsuchihara K
    BMC Cancer; 2019 Mar; 19(1):255. PubMed ID: 30898102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genomic profiling of murine mammary tumors identifies potential personalized drug targets for p53-deficient mammary cancers.
    Pfefferle AD; Agrawal YN; Koboldt DC; Kanchi KL; Herschkowitz JI; Mardis ER; Rosen JM; Perou CM
    Dis Model Mech; 2016 Jul; 9(7):749-57. PubMed ID: 27149990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Feasibility of real-time molecular profiling for patients with newly diagnosed glioblastoma without MGMT promoter hypermethylation-the NCT Neuro Master Match (N2M2) pilot study.
    Pfaff E; Kessler T; Balasubramanian GP; Berberich A; Schrimpf D; Wick A; Debus J; Unterberg A; Bendszus M; Herold-Mende C; Capper D; Schenkel I; Eisenmenger A; Dettmer S; Brors B; Platten M; Pfister SM; von Deimling A; Jones DTW; Wick W; Sahm F
    Neuro Oncol; 2018 May; 20(6):826-837. PubMed ID: 29165638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.